408 related articles for article (PubMed ID: 19016710)
1. Expression of toll-like receptor 2, NOD2 and dectin-1 and stimulatory effects of their ligands and histamine in normal human keratinocytes.
Kobayashi M; Yoshiki R; Sakabe J; Kabashima K; Nakamura M; Tokura Y
Br J Dermatol; 2009 Feb; 160(2):297-304. PubMed ID: 19016710
[TBL] [Abstract][Full Text] [Related]
2. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
4. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.
Begon E; Michel L; Flageul B; Beaudoin I; Jean-Louis F; Bachelez H; Dubertret L; Musette P
Eur J Dermatol; 2007; 17(6):497-506. PubMed ID: 17951129
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2 and 4 combination engagement upregulate IL-15 synergistically in human rheumatoid synovial fibroblasts.
Jung YO; Cho ML; Kang CM; Jhun JY; Park JS; Oh HJ; Min JK; Park SH; Kim HY
Immunol Lett; 2007 Mar; 109(1):21-7. PubMed ID: 17289161
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.
Bieneman AP; Chichester KL; Chen YH; Schroeder JT
J Allergy Clin Immunol; 2005 Feb; 115(2):295-301. PubMed ID: 15696084
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur.
Baroni A; Orlando M; Donnarumma G; Farro P; Iovene MR; Tufano MA; Buommino E
Arch Dermatol Res; 2006 Jan; 297(7):280-8. PubMed ID: 16283346
[TBL] [Abstract][Full Text] [Related]
8. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
9. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes.
Jarrousse V; Castex-Rizzi N; Khammari A; Charveron M; Dréno B
Eur J Dermatol; 2007; 17(6):492-6. PubMed ID: 17951128
[TBL] [Abstract][Full Text] [Related]
10. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes.
Kis K; Bodai L; Polyanka H; Eder K; Pivarcsi A; Duda E; Soos G; Bata-Csorgo Z; Kemeny L
Int Immunopharmacol; 2006 Mar; 6(3):358-68. PubMed ID: 16428071
[TBL] [Abstract][Full Text] [Related]
11. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.
Uehara A; Sugawara Y; Kurata S; Fujimoto Y; Fukase K; Kusumoto S; Satta Y; Sasano T; Sugawara S; Takada H
Cell Microbiol; 2005 May; 7(5):675-86. PubMed ID: 15839897
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells.
Shuang Chen ; Wong MH; Schulte DJ; Arditi M; Michelsen KS
J Endotoxin Res; 2007; 13(5):281-96. PubMed ID: 17986487
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S
J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test.
Kikkert R; Bulder I; de Groot ER; Aarden LA; Finkelman MA
J Endotoxin Res; 2007; 13(3):140-9. PubMed ID: 17621556
[TBL] [Abstract][Full Text] [Related]
15. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
[TBL] [Abstract][Full Text] [Related]
16. dsRNA-mediated innate immunity of epidermal keratinocytes.
Tohyama M; Dai X; Sayama K; Yamasaki K; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Nagai H; Takashima A; Hashimoto K
Biochem Biophys Res Commun; 2005 Sep; 335(2):505-11. PubMed ID: 16087162
[TBL] [Abstract][Full Text] [Related]
17. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines.
Uehara A; Fujimoto Y; Fukase K; Takada H
Mol Immunol; 2007 May; 44(12):3100-11. PubMed ID: 17403538
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.
Chang S; Dolganiuc A; Szabo G
J Leukoc Biol; 2007 Sep; 82(3):479-87. PubMed ID: 17595379
[TBL] [Abstract][Full Text] [Related]
19. Increased surface toll-like receptor 2 expression in superantigen shock.
Hopkins PA; Pridmore AC; Ellmerich S; Fraser JD; Russell HH; Read RC; Sriskandan S
Crit Care Med; 2008 Apr; 36(4):1267-76. PubMed ID: 18379254
[TBL] [Abstract][Full Text] [Related]
20. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes.
Tohyama M; Sayama K; Komatsuzawa H; Hanakawa Y; Shirakata Y; Dai X; Yang L; Tokumaru S; Nagai H; Hirakawa S; Sugai M; Hashimoto K
Int Immunol; 2007 Sep; 19(9):1095-102. PubMed ID: 17855433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
